Press Release: Alcyonels : Promising Treatment of Challenging Pediatric Brain Stem Tumor, DIPG, with Alcyone AMC Precision Delivery of Oncolytic Adenovirus

Alcyone Lifesciences, Inc., a leader in transforming Disease Modifying Therapies for CNS through Advanced Precision Delivery Platforms, announced encouraging progress by investigators at the Clínica Universidad de Navarra regarding the Alcyone MEMS Cannula (AMC) precision delivery of an oncolytic adenovirus in a small series of patients with a pediatric brain stem tumor, diffuse intrinsic pontine glioma (DIPG).